Combined excimer laser, topical tacrolimus treatment may be effective therapy for segmental vitiligo
Please provide your email address to receive an email when new articles are posted on . Combination therapy including a 308-nm excimer laser, topical tacrolimus and short-term systemic corticosteroids ...
Combination therapy with topical calcineurin inhibitors and excimer laser/light was more effective than excimer laser/light monotherapy in treating vitiligo, according to the recent study results.
Sept. 21, 2004 — Combination therapy with topical 0.1% tacrolimus ointment and the 308-nm excimer laser is significantly more effective than laser monotherapy in the repigmentation of ultraviolet (UV) ...
HORSHAM, Pa., Oct. 19, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: SSKN) STRATA Skin Sciences, Inc. (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
The MarketWatch News Department was not involved in the creation of this content. HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN) ...
June 10, 2002 -- The 308-nm excimer laser may prove to be the treatment of choice for vitiligo and psoriasis, based on results of two pilot studies reported in the May issue of the Journal of the ...
STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...
HORSHAM, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to advancing dermatologic care through ...
HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results